TCL Archive Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs June 16, 1999
TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences August 10, 2012